# Evaluating the potential of graphene oxide to promote skeletal muscle complex regeneration

**Authors:** Yulu Chen, Zeyu Zhu, Yian Shen, Xuling Liu, Yushi He, Chengqi Lyu, Jiayu Lu

PMC · DOI: 10.3389/fbioe.2025.1574145 · 2025-07-31

## TL;DR

This study shows that graphene oxide can enhance muscle and bone cell regeneration, offering a new approach for musculoskeletal tissue repair.

## Contribution

The study identifies optimal graphene oxide size and concentration for promoting muscle and bone cell interactions and regeneration.

## Key findings

- Graphene oxide with >500 nm size at 2.5 μg/mL boosts muscle cell proliferation and differentiation.
- GO activates the PI3K-Akt pathway and upregulates NFATc1, aiding myogenic differentiation.
- GO-treated cell exosomes enhance bone-related genes and reduce inflammation in osteoblasts.

## Abstract

Repair and regeneration of the musculoskeletal system are critical for maintaining mobility, physical function, and overall quality of life. This study aimed to optimize the size and concentration of graphene oxide (GO) to achieve a balance that enhances the proliferation and myogenic differentiation of C2C12 cells and investigate the underlying mechanisms, including the activation of key myogenic genes and signaling pathways. Additionally, the effects of exosomes derived from GO-treated C2C12 myoblasts on osteoblasts were explored.

C2C12 cells were cultured with different concentrations (0.1, 0.5, 2.5, 12.5, and 62.5 μg/mL) and particle sizes (>500 and <500 nm) of GO. Thereafter, cell viability, proliferation, cycle, and migration were evaluated via fluorescence staining, CCK-8, flow cytometry, and scratch assays, respectively. Immunofluorescence, polymerase chain reaction, and RNA sequencing (RNA-seq) were used to detect the effects of GO on C2C12 cell differentiation and explore the related molecular mechanisms. Furthermore, RNA-seq analysis was performed to investigate the impact of exosomes derived from GO-treated C2C12 myoblasts on MC3T3-E1 cells.

GO with particle sizes of >500 nm at a concentration of 2.5 μg/mL significantly enhanced C2C12 cell proliferation and myogenic differentiation. Increased GO conductivity played a crucial role in supporting MyoD expression and promoting myocyte differentiation, likely by modulating membrane electrical activity and facilitating intercellular signaling. These effects were associated with the activation of the PI3K-Akt signaling pathway and the upregulation of the NFATc1 gene, further highlighting the role of GO’s conductive properties in regulating myogenic differentiation. Exosomes derived from GO-treated myoblasts upregulated genes such as PDGFRB, COL12A1, and TBX2 while downregulating inflammation-related genes such as C3, thereby demonstrating the crosstalk between muscle and bone cells.

The conductive properties and surface roughness of GO significantly enhanced interactions between muscle and bone tissues, consequently facilitating effective musculoskeletal repair. This study suggests that GO can serve as a promising material for integrated approaches in musculoskeletal tissue engineering by promoting both myogenic differentiation and osteoblastic activity. Our findings highlight the potential utility of GO in regenerative medicine, offering a novel strategy for musculoskeletal regeneration.

## Linked entities

- **Genes:** MYOD1 (myogenic differentiation 1) [NCBI Gene 4654], NFATC1 (nuclear factor of activated T cells 1) [NCBI Gene 4772], PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159], COL12A1 (collagen type XII alpha 1 chain) [NCBI Gene 1303], TBX2 (T-box transcription factor 2) [NCBI Gene 6909], C3 (complement C3) [NCBI Gene 718]

## Full-text entities

- **Genes:** Tbx2 (T-box 2) [NCBI Gene 21385], Nfatc1 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1) [NCBI Gene 18018] {aka 2210017P03Rik, NF-ATc, NFAT2, NFATc, Nfatcb}, Col12a1 (collagen, type XII, alpha 1) [NCBI Gene 12816], Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Pdgfrb (platelet derived growth factor receptor, beta polypeptide) [NCBI Gene 18596] {aka CD140b, PDGFR-1, Pdgfr}, Myod1 (myogenic differentiation 1) [NCBI Gene 17927] {aka MYF3, MyoD, Myod-1, bHLHc1}
- **Diseases:** inflammation (MESH:D007249)
- **Chemicals:** CCK-8 (MESH:D012844), GO (MESH:C000628730)
- **Cell lines:** MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12350265/full.md

---
Source: https://tomesphere.com/paper/PMC12350265